/Global Next Generation Sequencing (NGS) Market to Witness Robust Expansion Throughout the Forecast Period 2021 – 2028
Global Next Generation Sequencing (NGS) Market to Witness Robust Expansion Throughout the Forecast Period 2021 – 2028
Global Next Generation Sequencing (NGS) Market
DBMR has added a new report titled Global Next Generation Sequencing (NGS) Market with data Tables for historical and forecast years represented with Chats & Graphs spread through Pages with easy to understand detailed analysis. Report delivers a far-reaching market research on the current conditions of the industry, potential of the market in the present and the future prospects from various points of views. Market drivers and market restraints evaluated in this report gives clear understanding about how the product is getting utilized in the recent period and also offer estimations about the future usage. Report covers the study about the market potential for each geographical region based on the
May 12, 2021 06:19 PM EDT
In April, Undercover footage that is very disturbing to watch was revealed from a Spanish research facility that experiments on non-human animals. Cruelty Free International (CFI) released the footage that was recorded at Madrid-based Vivotecnia. It revealed numerous cases of clear cruelty, some of which may have been against the rule.
Increasingly, however, scientists are searching for alternatives to such testing. Here are 7 groundbreaking instances.
(Photo : Pixabay)
1. Hormone-like Substances Test
The German Centre for the Protection of Laboratory Animals (Bf3R), which is among the German Federal Institute for Risk Assessment (BfR), has initiated a test to help in identifying the effect hormone-like substances have on human cells. There are various chemicals that can disturb or interfere with the hormones of the human body - the endocrine system - and lead to health problems. These are called endocrine disruptors.
Support OneGreenPlanet Being publicly-funded gives us a greater chance to continue providing you with high quality content. Please support us!
Support Us
Disturbing undercover footage from a Spanish research facility that tests on non-human animals came to light in April. Cruelty Free International (CFI) published the footage recorded at Madrid-based Vivotecnia. It showed numerous cases of apparent cruelty, some of which may have fallen foul of the law. EU law dictates that research facilities must choose methods of testing that cause the least amount of pain and suffering. Yet CFI recorded Vivotecnia staff, for example, drawing blood out of the eyes of conscious rats. CFI said the procedure should happen under anesthesia. Previous CFI investigations have shown “barbaric” mistreatment at other labs in the EU too.
Share
A U.S. Department of Agriculture inspector examines ferret cages. A new policy mandates that inspectors do lighter inspections at certain lab animal facilities. U.S. DEPARTMENT OF AGRICULTURE
USDA now only partially inspects some lab animal facilities, internal documents reveal
May. 5, 2021 , 8:00 AM
In February 2019, the U.S. Department of Agriculture (USDA) made a significant and apparently secret change to how it oversees laboratory animal welfare,
Science has learned. Instead of fully inspecting all of the nearly 1100 facilities that house monkeys, rabbits, and other creatures used in biomedical research, it mandated partial “focused” inspections for labs accredited by a private organization of veterinarians and scientists called AAALAC International.
Allows researchers to study effects of COVID-19 on cell growth and development Provides insight as to how various drugs impact viral spread
Globally, lung failure is one of the leading causes of death. Many conditions can affect and damage the lungs, including asthma, chronic obstructive pulmonary disease, influenza, pneumonia, and, most recently, COVID-19. To better understand respiratory diseases and develop new drugs faster, investigators from Brigham and Women s Hospital designed a 3D lung-on-a-chip model of the distal lung and alveolar structures, the tiny air sacs that take in oxygen as you breathe. With this innovation, researchers are actively studying how COVID-19 viral particles travel through airways and impact pulmonary cells. Notably, this technology enables scientists to investigate how various COVID-19 therapies, such as remdesivir, impact the replication of the virus. Their results are published in